Company / Operating Income per Share
Crinetics Pharmaceuticals, Inc. Operating Income per Share History
FY2016-FY2025 · Annual data · Source: SEC filings
At a glance
Latest annual filing availableLatest Operating Income per Share
-$5.41
FY2025
5-year range
-$5.41 / -$2.26
FY2021-FY2025
Trend
-48.3%
vs FY2024
Sector context
#172 of 201
Health Care
What the data says
Crinetics Pharmaceuticals, Inc.'s operating income per share of $-5.41 is lower than 86% of companies in the Health Care sector (FY2025). Operating Income per Share has fluctuated over the past 10 years, ranging from $-379.33 in FY2019 to $-1.18 in FY2020.
Based on SEC 10-K filings.
-5.41 in FY2025.
Declined from $-3.83 to $-5.41 over the past 2 years.
Health Care sector context is included.
Operating Income per Share over time
Growth rates
- 3-Year CAGR
- -
- 5-Year CAGR
- -
- 10-Year CAGR
- -
Sector benchmark
Bottom 14% in Health CareTop 86% of 201This company -$5.41 Sector average -$28.56
▼
+81.1% above sector average
Key checks
Key Insights
- In FY2025, operating income per share decreased 48.3% year-over-year.
- Ranks #172 out of 201 companies in the Health Care sector.
- Peak operating income per share was recorded in FY2020.
- Lowest operating income per share in the period was in FY2019.
Company context
Key Data Points
- Low Piotroski F-Score: 2/9 (multiple financial health concerns)
- High earnings quality (cash-backed earnings)
Data sourced from SEC EDGAR filings. Not investment advice.
Annual data
| Year | Operating Income per ShareValue | YoY GrowthYoY |
|---|---|---|
| FY2025 | -$5.41 | -48.3% |
| FY2024 | -$3.65 | +4.9% |
| FY2023 | -$3.83 | -23.0% |
| FY2022 | -$3.12 | -37.7% |
| FY2021 | -$2.26 | -91.2% |
| FY2020 | -$1.18 | +99.7% |
| FY2019 | -$379.33 | -9625.3% |
| FY2018 | -$3.90 | +41.4% |
| FY2017 | -$6.66 | -11.4% |
| FY2016 | -$5.98 | - |
As of FY2025 · SEC 10-K · Updated Jul 2, 2026